Mirum Pharmaceuticals在欧洲肝病研究学会国际肝病大会上公布罕见肝病项目新数据

美股速递
May 31

Mirum Pharmaceuticals, Inc. (MIRM) 宣布,其针对罕见肝病的研究项目所取得的最新数据,已在2026年欧洲肝病研究学会(EASL)国际肝病大会上正式公布。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10